Conmoción Avanzar Artístico novartis ceo vas narasimhan Marchito monitor Listo
Novartis 2019: habla el CEO | PharmaBiz.NET
Watch CNBC's full interview with Novartis CEO Vas Narasimhan
Novartis CEO Vas Narasimhan urges global push for free and open movement of trade and talent - The Hindu BusinessLine
Basel is very open to newcomers - Basel Area Business & Innovation
Novartis CEO sees 'better place' with Covid by year-end | Mint
El CEO Vasant Narasimhan del fabricante suizo de drogas Novartis hace un discurso durante la ceremonia de apertura de la nueva fábrica de terapia celular y génica de la compañía en Stein,
There's an explosion of data & digital opportunities in Indian healthcare: Vasant Narasimhan, CEO, Novartis - The Economic Times
Novartis CEO Vas Narasimhan on Culture, Strategy and Change
Novartis's Vas Narasimhan on AI, Data Science for Company Operations
Novartis CEO Steers Drug Maker Back to R&D - WSJ
Novartis' CEO on gene therapy, innovation, and the company pivot - STAT
Novartis continúa la transformación en una empresa líder de medicamentos
El director ejecutivo, Vas Narasimhan, del fabricante suizo de drogas Novartis, se dirige a la conferencia de prensa anual de la compañía en Basilea, Suiza, el 30 de enero de 2019. REUTERS/Arnd
Un médico para Novartis | Economía | EL PAÍS
Novartis prevé destinar más de 8.800 millones a la compra de otras empresas en 2019 | PlantaDoce
Una vacuna no bastará para combatir el covid, dice jefe de Novartis
Novartis CEO Vas Narasimhan talks PhRMA, gene therapy, and more - STAT
CEO of Novartis pinning hopes on malaria drug - Basel Area Business & Innovation
Novartis: Vasant Narasimhan ist der jüngste CEO in der Riege - manager magazin
Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company - YouTube
تويتر \ Novartis على تويتر: "Today we announce Vas Narasimhan as new Novartis CEO from Feb 1, 2018. Thank you 👏 Joe Jimenez for your achievements https://t.co/2VauFSX2Be https://t.co/80YIKxip4I"
Embassy of India, Berne, Switzerland : Events/Photo Gallery
Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on sales | Fierce Pharma
Vas Narasimhan: the American trying to reshape Novartis | Financial Times
The CEO of Novartis on Developing Drugs During a Pandemic | WIRED
Novartis CEO Vasant Narasimhan Sees Consistent Growth While Sitting on Cash | Barron's
Vas Narasimhan knew what to expect as Novartis CEO—or so he thought: NYT | Fierce Pharma